Meta-analysis of the association of enteroviruses with human heart disease

Heart

Volumn 78, Issue 6, 1997, Pages 539-543

  Baboonian, Christina ^a   Treasure, Tom ^a  

^a ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

Dilated cardiomyopathy; Enteroviruses; Meta analyses; Myocarditis

Indexed keywords

VIRUS RNA;

DISEASE ASSOCIATION; ENTEROVIRUS INFECTION; HEART DILATATION; HUMAN; META ANALYSIS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; REVIEW; RNA ANALYSIS; VIRUS MYOCARDITIS;

EID: 0031454913     PISSN: 13556037     EISSN: None     Source Type: Journal    
DOI: 10.1136/hrt.78.6.539     Document Type: Review

References (55)

1. Van Creveld S, DeJager H. Myocarditis in new-borns caused by Coxsackie virus. Clinical and pathological data. Ann Pediatr 1956;187:100-12.
2. Javett SN, Heyman S, Mundel B, Pepler WJ, Lurie HI, Gear J, et al. Myocarditis in the new-born infant. J Pediatr 1956; 48:1-22.
3. Montgomery J, Gear J, Prinsloo FR, Kahn M, Kirsh ZG. Myocarditis of new-born; outbreak in maternity home in Southern Rhodesia associated with coxsackie group B virus infection. S Afr Med J 1955;29:608-18.
4. Brown GC, Karunas RS. Relationship of congenital anomalies and maternal infection with selected enteroviruses. Am J Epidemiol 1972;95:207-17.
5. Zvizdic S, Seric K, Radovic S, Selak I. Izolacija virusa iz obdukcionog materijala za vrijeme epidemije coxsackie viroza, u Sarajevu 1985. Med Arh 1990;44:39-42.
6. Burch GE, Sun SC, Chu K, Sohal R, Colcolough H. Interstitial and coxsackie virus B myocarditis in infants and children. A comparative histologic and immunofluorescent study of 50 autopsied hearts. JAMA 1968;203:1-8.
7. Basso NG, Fonseca ME, Garcia AG, Zuardi JA, Silva MR, Outani H. Enterovirus isolation from foetal and placental tissues. Acta Virol 1990;34:49-57.
8. Dommergues M, Petitjean J, Aubry MC, Delezoide AL, Narcy F, Fallet-Bianco C, et al. Fatal enteroviral infection with cerebral ventriculomegaly and cardiomyopathy. Fetal Diag Ther 1994;9:77-78.
9. Longson M, Cole FM, Davies D. Isolation of a coxsackie virus group B, type 5, from the heart of a fatal case of myocarditis in an adult. J Clin Pathol 1969;22:654-8.
10. Monaldi TD, Benedetto A, Montalto TT. Pericarditis infection due to coxsackie virus group B, type 2. BMJ 1963;ii:1451-2.
11. Soutar CA. Unusual case of viral pericarditis. Lancet 1971;i: 498.
12. El-Hagrassy MMO, Banatvala JE, Coltart DJ. Coxsackie-B-virus-specific IgM responses in patients with cardiac and other diseases. Lancet 1980;ii:1160-2.
13. Bell EJ, McCartney RA. A study of coxsackie B virus infections, 1972-1983. J Hyg 1984;93:197-203.
14. McCartney RA, Banatvala JE, Bell EJ. Routine use of u-antibody capture ELISA for serological diagnosis of coxsackie B virus infections. J Med Virol 1986;19:205-12.
15. Hilton DA, Variend S, Pringle JH Demonstration of coxsackie virus RNA in formalin-fixed tissue sections from childhood myocarditis cases by in situ hybridization and polymerase chain reaction. J Pathol 1993;170:45-51.
16. Martin AB, Webber S, Fricker J, Jaffe R, Demmler G, Kearney D, et al. Acute myocarditis. Rapid diagnosis by PCR in children. Circulation 1994;90:330-9.
17. Towbin JA. Diagnosis and management of myocarditis in children. The second international meeting on advances in understanding and management of the cardiomyopathies [abstract]. La Coruna, Spain, 1996.
18. Jin O, Sole MJ, Butany JW, Chia WK, McLaughlin PR, Liu P, et al. Detection of Enterovirus RNA in myocardial biopsies from patients with myocarditis and cardiomyopathy using gene amplification by polymerase chain reaction. Circulation 1990;82:8-16.
19. Nicholson F, Ajetunmobi JF, Shackleton EA, Starkey WG, Illavia SJ, Muir P, et al. Molecular detection and serotype analysis of enterovirus RNA in archival specimens from patients with acute myocarditis. Br Heart J 1995;74:522-7.
20. Weiss L, Movahed L, Billingham ME, Cleary ML. Detection of coxsackie B3 RNA in myocardial tissues by polymerase chain reaction. Am J Pathol 1991;138:497-503.
21. Petitjean J, Kopecka H, Freymuth F, Langlard JM, Scanu P, Galateau F, et al. Detection of enteroviruses in endomyocardial biopsy by molecular approach. J Med Virol 1992;37:76-82.
22. Giacca M, Severini GM, Mestroni L, Salvi A, Lardieri G, Falaschi A, et al. Low frequency of detection by nested polymerase chain reaction of enterovirus ribonucleic acid in endomyocardial tissue of patients with idiopathic dilated cardiomyopathy. J Am Coll Cardiol 1994;24:1033-40.
23. Koide H, Kitaura Y, Deguchi H, Ukimura A, Kawamura K, Hirai K. Genomic detection of enteroviruses in the myocardium studies on animal hearts with coxsackie B3 myocarditis and endomyocardial biopsies from patients with myocarditis and dilated cardiomyopathy. Jpn Circ J 1992;56:1081-93.
24. Satoh M, Tamura G, Segawa I. Enteroviral RNA in endomyocardial biopsy tissues of myocarditis and dilated cardiomyopathy. Pathol Int 1994;44:345-51.
25. Bowles NE, Richardson PJ, Olsen EGJ, Archard LC. Detection of coxsackie B virus specific RNA sequences in myocardial biopsy samples from patients with myocarditis and dilated cardiomyopathy. Lancet 1986;i:1120-3.
26. Ueno H, Yokota Y, Shiotani H, Yokoyama M, Itoh H, Ishido S, et al. Significance of detection of enterovirus RNA in myocardial tissues by reverse transcription-polymerase chain reaction. Int J Cardiol 1995;51:157-64.
27. Grasso M, Arbustini E, Silini E, Diegoli M, Percivalle E, Ratti G, et al. Search for coxsackie virus B3 RNA in idiopathic dilated cardiomyopathy using gene amplification by polymerase chain reaction. Am J Cardiol 1992;69:658-64.
28. Liljeqvist JA, Bergstrom T, Holmstrom S, Samuelson A, Yousef GE, Waagstein F, et al. Failure to demonstrate enterovirus aetiology in Swedish patients with dilated cardiomyopathy. J Med Virol 1993;39:6-10.
29. Muir P, Nicholson F, Illavia SJ, McNeil TS, Ajetunmobi JF, Dunn H, et al. Serological and molecular evidence of enterovirus infection in patients with end-stage dilated cardiomyopathy. Heart 1996;76:243-9.
30. Keeling PJ, Jeffrey S, Caforio ALP, Taylor R, Bottazzo GF, Davies MJ, et al. Similar prevalence of enteroviral genome within the myocardium from patients with idiopathic dilated cardiomyopathy and controls by the polymerase chain reaction. Br Heart J 1992;68:554-9.
31. Zoll GJ, Melchers WJG, Kopecka H, Jambroes G, van der Poel HJA, Galama MD. General primer-mediated polymerase chain reaction for detection of enteroviruses: Application for diagnostic routine and persistent infections. J Clin Microbiol 1992;30:160-5.
32. Marti V, Coll P, Ballester M, Obrador D, Carrio I, Moya C, et al. Enterovirus persistence and myocardial damage detected by 111In-monoclonal antimyosin antibodies in patients with dilated cardiomyopathy. Eur Heart J 1996;17: 545-9.
33. Bowles NE, Rose ML, Taylor P, Banner NR, Morgan-Capner P, Cunningham L, et al. End-stage dilated cardiomyopathy persistence of enterovirus RNA in myocardium at cardiac transplantation and lack of immune response. Circulation 1989;80:1128-36.
34. Schwaiger A, Umlauft F, Weyrer K, Larcher C, Lyons J, Muhlberger V, et al. Detection of enteroviral ribonucleic acid in myocardial biopsies from patients with idiopathic dilated cardiomyopathy by polymerase chain reaction. Am Heart J 1993;126:406-10.
35. Khan M, Why H, Richardson P, Archard L. Nucleotide sequencing of PCR products shows the presence of coxsackie-B3 virus in endomyocardial biopsies from patients with myocarditis or dilated cardiomyopathy. Biochem Soc Trans 1994;22:176S.
36. Andreoletti L, Wattre P, Decoene C, Lobert PE, Dewilde A, Hober D. Detection of enterovirus-specific RNA sequences in explanted myocardium biopsy specimens from patients with dilated or ischaemic cardiomyopathy. Clin Infect Dis 1995;21:1315-17.
37. Chiang FT, Lin Li, Tseng YZ, Tseng CD, Hsu KL, Wu TL, et al. Detection of enterovirus RNA in patients with idiopathic dilated cardiomyopathy by polymerase chain reaction. Taiwan I Hsueh Hui Tsu Chih 1992;91:569-74.
38. Keeling PJ, Lukaszyk A, Poloniecki J, Caforio ALP, Davies MJ, Booth JC, et al. A prospective case-control study of antibodies to coxsackie B virus in idiopathic dilated cardiomyopathy. J Am Coll Cardiol 1994;23:593-8.
39. Cambridge G, MacArthur CG, Waterson AP, Goodwin JF, Oakley CM. Antibodies to coxsackie B viruses in congestive cardiomyopathy. Br Heart J 1979;41:692-6.
40. Kutaura Y. Experimental coxsackie B virus myocarditis in mice: 18 month histopathological and virological study. Jpn Circ J 1981;45:747-62.
41. Morita H. Experimental coxsackie B-3 virus myocarditis in golden hamsters. Light and electron microscopy findings in a long-term follow-up study. Jpn Circ J 1981;45:713-29.
42. Eschenhagen T, Diederich M, Kluge SH, Magnussen O, Mene U, Muller F, et al. Bovine hereditory cardiomyopathy: an animal model of human dilated cardiomyopathy. J Mol Cell Cardiol 1995;27:357-70.
43. Hajjar RJ, Liao R, Young JE, Fuleihan F, Glass MG, Gwathmey JK. Pathophysiological and biochemical characterisation of an avian model of dilated cardiomyopathy: comparison to findings in human dilated cardiomyopathy. Cardiovasc Res 1993;27:2212-21.
44. Gruver EJ, Glass MG, Marsh JD, Gwathmey JK. An animal model of dilated cardiomyopathy: characterisation of dihydropyridine receptors and contractile performance. Am J Physiol 1993;265:H1704-11.
45. Liao R, Nascimben L, Friedrich J, Gwathmey JK, Ingwall JS. Cardiovascular energy reserve in an animal model of dilated cardiomyopathy. Relationship to contractile performance. Circ Res 1996;78:893-902.
46. Genao A, Seth K, Schmidt U, Carles M, Gwathmey JK. Dilated cardiomyopathy in turkeys: an anima model for the study of human heart failure. Lab Anim Sci 1996;46:399-404.
47. Chow LH, Beisel KW, McManus BM. Enteroviral infections of mice with severe combined immunodeficiency. Evidence for direct viral pathogenesis of myocardial injury. Lab Invest 1992;66:24-31.
48. Khatib R, Chason JL, Silberberg BK, Lerner AM. Age dependent pathogenicity of group B Coxsackieviruses in Swiss-Webster mice: infectivity for myocardium and pancreas. J Infect Dis 1980;141:394-403.
49. Woodruff JF, Woodruff JJ. Involvement of T lymphocytes in the pathogenesis of coxsackievirus B3 heart disease. J Immunol 1974;113:1726-34.
50. +T lymphocytes in coxsackievirus B3-induced myocarditis. J Virol 1995;69:6720-8.
51. Schwimmbeck PL, Badorff C, Rohn G, Schulze K, Schultheiss HP. The role of sensitised T-cells in myocarditis and dilated cardiomyopathy. Int J Cardiol 1996;54:117-25.
52. Lauer B, Padberg K, Schultheiss HP, Strauer BE. Autoantibodies against cardiac myosin in patients with myocarditis and dilated cardiomyopathy. Z Kardiologie 1995;84:301-10.
53. Caforio ALP. Role of autoimmunity in dilated cardiomyopathy. Br Heart J 1994;72(suppl):S30-4.
54. Tracy S, Chapman NM, Romero J, Ramsingh AI. Genetics of coxsackievirus B cardiovirulence and inflammatory heart muscle disease. Trends Microbiol 1996;4:175-9.
55. Huber SA, Lodge PA. Coxsackievirus B3 myocarditis. Identification of different pathogenic mechanisms in DBA/2 and Balb/c mice. Am J Pathol 1986;122:284-91.